反応 #528634
ord-9c2af65114bc4a499f286d766635700b
反応方程式
反応物
試薬
反応条件
後処理
- 1workup.ADDITIONis charged into a glass reaction vessel
- 2その他equipped with a mechanical stirrer
- 3workup.ADDITIONis slowly added
- 4workup.ADDITIONAfter the addition
- 5workup.STIRRINGis stirred for an additional period of about 20 minutes
- 6その他completion of the reaction
- 7ろ過After this time the reaction mixture is filtered
- 8その他resulting in the formation of a precipitate
- 9ろ過This precipitate is recovered by filtration
- 10workup.DISSOLUTIONis dissolved in ether
- 11洗浄The ether solution is washed with dilute aqueous sodium carbonate
- 12乾燥is dried over anhydrous magnesium sulfate
- 13ろ過is filtered
実験手順
Tetrahydro-1-(5-methylsulfonyl-1,3,4-thiadiazol-2-yl)-3-allyl-6-hydroxy-2(1H)-pyrimidinone (0.05 mole) dissolved in pyridine (80 ml) is charged into a glass reaction vessel equipped with a mechanical stirrer and thermometer. The solution is cooled to a temperature of about 10° C. and propargyl chloroformate (0.06 mole) dissolved in pyridine (25 ml) is slowly added with stirring over a period of about 15 minutes. After the addition is completed, the reaction mixture is warmed to room temperature and is stirred for an additional period of about 20 minutes to ensure completion of the reaction. After this time the reaction mixture is filtered. The filtrate is then combined with water (100 ml) resulting in the formation of a precipitate. This precipitate is recovered by filtration and is dissolved in ether. The ether solution is washed with dilute aqueous sodium carbonate, is dried over anhydrous magnesium sulfate and is filtered. The filtrate is then stripped of ether to yield the desired product tetrahydro-1-(5-methylsulfonyl-1,3,4-thiadiazol-2-yl)-3-allyl-6-propargyloxycarbonyloxy-2(1H)-pyrimidinone as the residue.